Barclays »

Aikido Pharma shares owned by Barclays

Quarter-by-quarter ownership of Aikido Pharma (DOMH) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aikido Pharma

Tip: Access up to 7 years of quarterly data

All positions including Aikido Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aikido Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9k 915 3.14
2025-03-31 $0 31 0.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Aikido Pharma

Citadel Advisors
Vanguard Capital Management
Creek Drive Management Group
Philadelphia Financial Management of San Francisco
Connective Capital Management
BlackRock
Jane Street
Geode Capital Management
Vanguard Fiduciary Trust
State Street Corporation
Northern Trust
Steward Partners Investment Advisory
Susquehanna Advisors Group
Morgan Stanley
Cambridge Investment Research Advisors

View all funds holding Aikido Pharma